Palisade Bio Management

Management criteria checks 1/4

Palisade Bio's CEO is J. Finley, appointed in Apr 2021, has a tenure of 3.25 years. total yearly compensation is $1.28M, comprised of 40.7% salary and 59.3% bonuses, including company stock and options. directly owns 1.44% of the company’s shares, worth €56.94K. The average tenure of the management team and the board of directors is 3.3 years and 0.9 years respectively.

Key information

J. Finley

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage40.7%
CEO tenure3.3yrs
CEO ownership1.4%
Management average tenure3.3yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has J. Finley's remuneration changed compared to Palisade Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$14m

Dec 31 2023US$1mUS$520k

-US$12m

Sep 30 2023n/an/a

-US$13m

Jun 30 2023n/an/a

-US$14m

Mar 31 2023n/an/a

-US$13m

Dec 31 2022US$614kUS$441k

-US$15m

Sep 30 2022n/an/a

-US$9m

Jun 30 2022n/an/a

-US$358k

Mar 31 2022n/an/a

-US$27m

Dec 31 2021US$1mUS$365k

-US$27m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$39m

Mar 31 2021n/an/a

-US$12m

Dec 31 2020US$532kUS$293k

-US$10m

Compensation vs Market: J.'s total compensation ($USD1.28M) is above average for companies of similar size in the German market ($USD525.52K).

Compensation vs Earnings: J.'s compensation has increased whilst the company is unprofitable.


CEO

J. Finley (66 yo)

3.3yrs

Tenure

US$1,277,100

Compensation

Mr. J. D. Finley serves as its Chief Executive Officer of Palisade Bio, Inc. since 2023 and has been its Director since February 2023. He serves as the Chief Financial Officer at Palisade Bio, Inc. (Altern...


Leadership Team

NamePositionTenureCompensationOwnership
J. Finley
CEO, CFO & Director3.3yrsUS$1.28m1.44%
€ 56.9k
Mitchell Jones
COO & Chief Medical Officerless than a yearUS$738.81k0.41%
€ 16.3k
Ryker Willie
Senior VP of Finance & Corporate Controller6.1yrsno datano data

3.3yrs

Average Tenure

Experienced Management: 7NS0's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
J. Finley
CEO, CFO & Director1.4yrsUS$1.28m1.44%
€ 56.9k
Margery Fischbein
Independent Directorless than a yearno datano data
Donald Williams
Independent Chairman of the Board3.3yrsUS$87.23k0.36%
€ 14.1k
Bruce Sands
Member of Clinical Advisory Boardless than a yearno datano data
Binxian Wei
Independent Director5.4yrsUS$67.63k0.050%
€ 2.0k
Florian Rieder
Member of Clinical Advisory Boardless than a yearno datano data

0.9yrs

Average Tenure

66yo

Average Age

Experienced Board: 7NS0's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/03 15:38
End of Day Share Price 2024/04/05 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Palisade Bio, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaBrookline Capital Markets
Aydin HuseynovLadenburg Thalmann & Company
Jason McCarthyMaxim Group